http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101948385-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101948385-B1 |
| titleOfInvention | Novel Biomarker for Analysing Prognosis of Prostate Cancer and Their Uses |
| abstract | The present invention provides a novel biomarker for prostate cancer prognosis analysis. The present invention is based on the finding that the expression of SPINK1 or SP8 shows an increasing or decreasing pattern in patients at risk of progression to hormone refractory prostate cancer. Thus, using the marker of the present invention, the prognosis of prostate cancer can be analyzed quickly and accurately. When the marker of the present invention is used, it is possible to predict the progression or progression to hormone refractory prostate cancer, and thus it is possible to more effectively cope with the treatment of the patient. |
| priorityDate | 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 589.